Will GLP-1–associated weight loss drive demand for abdominoplasty?
Industry Buzz
The GLP-1s have created a huge influx of patients who have undergone massive weight loss and thus are left with resulting loose skin all around.
—Sheina Bawa, MD
Surgical readiness comes down to three pillars: weight stability (ideally 3–6 months), nutritional adequacy, and psychological readiness. Rapid weight loss is a moving target: operating too early is like tailoring a dress mid-alteration.
—Gina Maccarone, MD
GLP-1 receptor agonists have shifted obesity management. Rapid, large-volume weight loss has exposed a secondary issue: excess skin. Plastic surgeons report rising consultations tied to post–GLP-1 body contouring.
Semaglutide and tirzepatide trials report mean weight loss ranging from roughly 10% to over 20% of baseline body weight, as shown in the STEP and SURMOUNT Phase 3 programs.[][][] These outcomes mirror results seen after bariatric surgery in selected patients. Excess redundant skin post treatment follows similar patterns, though.[]
Abdominoplasty remains the definitive surgical option for such redundant abdominal tissue. However, there are risks related to the procedure, including seroma, infection, venous thromboembolism, pulmonary embolism, and capsular contracture. Complication rates vary from 10% to 20% depending on patient factors and surgical technique. Risk rises with higher BMI, smoking, diabetes, and use of general anesthesia.[]
Post–weight-loss patients often present with nutritional deficits and altered wound healing profiles, especially after rapid pharmacologic weight reduction. These factors complicate surgical planning.
Demand for panniculectomy and abdominoplasty have risen in parallel with weight loss interventions. A similar trend was also observed in the early 2000s with bariatric surgery expansion.[][]
Post GLP-1, patients flock to plastic surgeons
When asked if specialists are seeing an increased demand for post–GLP-1 procedures, Gina Maccarone, MD, a triple board-certified cosmetic surgeon and founder of The Surgeonista, replied, “Absolutely.”
Catherine Hannan, MD, a board-certified plastic surgeon from Washington, DC, said, “This trend is considerably larger than what we observed with bariatric surgery in the 2000s and 2010s.”
Board-certified plastic surgeon Rachel Ford, MD, concurred, saying, “I have definitely seen an increase in consultations for aesthetic procedures following GLP-1–related weight loss.”
Sheina Bawa, MD, general/cosmetic surgeon and founder of MetamorphMD, adds, “The GLP-1s have created a huge influx of patients who have undergone massive weight loss and thus are left with resulting loose skin all around.”
She goes on to explain the extent of the surgical needs. “Abdominoplasty is certainly a very common procedure we perform after patients have used GLP-1s. It allows us to remove the excess skin. However, more often than not, these patients need total body lifts along with arm and thigh lifts because the loose skin after weight loss is all around. Additionally, the weight loss is also seen in the face and thus warrants a face and neck lift many times.”
Dr. Maccarone said, “GLP-1–associated weight loss has created a new wave of patients who look 'smaller' but don’t feel finished—because volume loss and skin laxity become the next frontier.”
The abdominoplasty profile
In the United States, abdominoplasty remains a high-volume procedure, with roughly 140,000 to 170,000 cases performed annually. However, abdominoplasty carries a low but measurable mortality risk, estimated at approximately 1 in 10,000 to 1 in 13,000 procedures.[]
Risk increases when abdominoplasty is combined with other procedures such as liposuction, with significantly higher complication rates reported in combined operations.[][][]
Patients who have undergone bariatric surgery have usually had prior severe obesity. As a rule, this is not the case with GLP-1 users. These patients usually lack experience with body image changes after weight loss. That’s why expectations for surgical outcomes may not match reality.
Dr. Ford adds, “For these patients, it is best to lose weight gradually over time to allow the body to adjust both cosmetically and metabolically.”
So, how to determine surgical readiness?
Dr. Ford answers the question this way: “Patients should maintain a stable weight for at least several months prior to surgery, ideally close to their goal weight, as significant weight fluctuations afterward can impact results."
"I advise patients to discontinue these medications 3 weeks prior to surgery to reduce risks associated with general anesthesia," Dr. Ford adds. "I also recommend a nutritious, high-protein diet both before surgery and during recovery. Patients using GLP-1 medications may be at risk for malnutrition due to decreased appetite, which is not ideal when preparing for surgery.”
Dr. Maccarone said, “Surgical readiness comes down to three pillars: weight stability (ideally 3–6 months), nutritional adequacy, and psychological readiness. Rapid weight loss is a moving target: operating too early is like tailoring a dress mid-alteration. I also assess protein intake, micronutrient status, and whether expectations are grounded in reality vs urgency.”
Ronald Rosso, MD, a plastic surgeon in the South Bay area of Los Angeles, said, “Surgical approval/readiness is based on a set of standards that vary from insurance company to insurance company but, in general, are as follows: (a) Patients should have lost, depending on their height and body type, between 70 to 100 lbs and have maintained that weight for at least one year. (b) A patient needs to have documented evidence of skin infection or rash by their primary care physician. (3) A patient's large abdominal pannus should be documented by their primary care physician to cause problems with the patient's activities of daily living.”
GLP-1 therapy has expanded access to weight loss interventions. Secondary demand for body contouring appears likely. Whether complication rates rise depends on patient selection and interdisciplinary coordination.